Skip to main content
Log in

Gentamicin disposition and tissue accumulation on multiple dosing

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Gentamicin pharmacokinetics was examined in a group of 47 patients with stable renal function treated an average of 10 days for severe infection. Serum concentrations rose continually during treatment, and declined in two phases after the drug was stopped, with a mean half-life of 112hr (range 27–693 hr) in the second phase. A two-compartment model was used to describe the biphasic decline in serum concentrations and to calculate the amount of drug in the tissue compartment at all times during and after treatment. Predicted tissue amounts of gentamicin rose continually on multiple dosing in all patients. In six patients who died, postmortem tissues were obtained to quantitate recovery. In all cases, the predicted amount of gentamicin in tissues was in close agreement with the amount recovered at autopsy. Tissue distribution and accumulation constitute a major reason for variability in gentamicin pharmacokinetics and explain both the rising peak and trough serum concentrations and the prolonged detection of gentamicin in serum and urine after the drug is stopped.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. R. E. Cutler, A. M. Gyselynck, W. P. Fleet, and A. W. Forrey. Correlation of serum creatinine concentration and gentamicin half-life.J. Am. Med. Assoc. 219:1037–1041 (1972).

    Article  CAS  Google Scholar 

  2. D. Kaye, M. E. Levison, and E. D. Labovitz. The unpredictability of serum concentrations of gentarnicin: Pharmacokinetics of gentamicin in patients with normal and abnormal renal function.J. Infect. Dis. 130:150–154 (1974).

    Article  CAS  PubMed  Google Scholar 

  3. M. Barza, R. B. Brown, D. Shen, M. Gibaldi, and L. Weinstein. Predictability of blood levels of gentamicin in man.J. Infect. Dis. 132:165–174 (1975).

    Article  CAS  PubMed  Google Scholar 

  4. J. G. Dahlgren, E. T. Anderson, and W. L. Hewitt. Gentamicin blood levels: A guide to nephrotoxicity.Antimicrob. Agents Chemother. 8:58–62 (1975).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. G. Kahlmeter and C. Kamme. Prolonged excretion of gentarnicin in a patient with unimpaired renal function.Lancet 1:286 (1975).

    Article  CAS  PubMed  Google Scholar 

  6. J. J. Schentag and W. J. Jusko. Gentamicin persistence in the body.Lancet 1:486 (1977).

    Article  CAS  PubMed  Google Scholar 

  7. J. J. Schentag, W. J. Jusko, M. E. Plaut, T. J. Cumbo, J. W. Vance, and E. Abrutyn. Tissue persistence of gentamicin in man.J. Am. Med. Assoc. 238:327–329 (1977).

    Article  CAS  Google Scholar 

  8. K. Siersbaek-Nielsen, J. M. Hansen, J. Kampmann, and M. Kristensen. Rapid evaluation of creatinine clearance.Lancet 1:1133 (1971).

    Article  CAS  PubMed  Google Scholar 

  9. R. A. Chan, E. J. Benner, and P. D. Hoeprich. Gentamicin therapy in renal failure: A nomogram for dosage.Ann. Intern. Med. 76:773–778 (1972).

    Article  CAS  PubMed  Google Scholar 

  10. R. E. Winters, K. D. Litwack, and W. L. Hewitt. Relation between dose and levels of gentamicin in blood.J. Infect. Dis. Suppl. 124:S90-S95 (1971).

    Article  CAS  PubMed  Google Scholar 

  11. C. M. Kunin. Binding of antibiotics to tissue homogenates.J. Infect. Dis. 121:55–64 (1970).

    Article  CAS  PubMed  Google Scholar 

  12. C. M. Metzler.NONLIN: A Computer Program for Parameter Estimation in Nonlinear Situations, Technical Report No. 7292/69/7292/005, Upjohn Company, Kalamazoo, Mich., Nov. 25, 1969.

    Google Scholar 

  13. M. Gibaldi and D. Perrier.Drugs and the Pharmaceutical Sciences, Vol. 1:Pharmacokinetics, J. Swarbrick (ed.), Marcel Dekker, New York, 1975, p. 119.

    Google Scholar 

  14. B. J. Devine, Gentamicin Therapy.Drug Intell. Clin. Pharmacol. 8:650–655 (1974).

    Google Scholar 

  15. J. J. Schentag and W. J. Jusko. Renal clearance and tissue accumulation of gentamicin.Clin. Pharmacol. Ther. in press (1977).

  16. C. Q. Edwards, C. R. Smith, K. L. Baughman, J. F. Roger, and P. S. Leitman. Concentrations of gentamicin and amikacin in human kidneys.Antimicrob. Agents Chemother. 9:925–927 (1976).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. F. C. Luft and S. A. Kleit. Renal parenchymal accumulation of aminoglycoside antibiotics in rats.J. Infect. Dis. 130:656–659 (1974).

    Article  CAS  PubMed  Google Scholar 

  18. D. Lalka, W. J. Jusko, and T. J. Bardos. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems. II. Comparative pharmacokinetics in dogs.J. Pharm. Sci. 65:230–235 (1975).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by Grant GM 20852 from the National Institutes of General Medical Sciences, NIH.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schentag, J.J., Jusko, W.J., Vance, J.W. et al. Gentamicin disposition and tissue accumulation on multiple dosing. Journal of Pharmacokinetics and Biopharmaceutics 5, 559–577 (1977). https://doi.org/10.1007/BF01059684

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01059684

Key words

Navigation